Mild asthma. For patients showing wheezing and shortness of breath on moderate exertion, it’s one of the most common diagnoses, even when breath sounds are clear and pulmonary function testing is normal. What makes mild asthma “mild”? The key guidelines base the stage of a patient’s asthma on how difficult it is to treat. Does that mean the frequency of symptom occurrence? How often a rescue inhaler needs to be used? The frequency and severity of pulmonary exacerbations? How should mild asthma be treated? What are the risks and benefits of short-acting beta agonists versus long-acting beta agonists versus inhaled corticosteroids? Which combinations might be appropriate for which patients?Join us in this issue of ePulmonology Review, as Dr. Fawzy from the Johns Hopkins University School of Medicine’s Division of Pulmonary and Critical Care discusses these and other issues important to providing the best care for patients with mild asthma.Post test for CME/CE credit: https://elit.dkbmed.com/issues/197/test Hosted on Acast. See acast.com/privacy for more information.
--------
23:47
PH in the Clinic: The Revised WHO Classifications
Pulmonary hypertension. The 2022 ESC/ERS revised guidelines have redefined it. New evidence from ongoing and completed clinical trials have led to updates in diagnostic thresholds and treatment algorithms. New agents — some approved, others advancing through the pipeline — promise improved efficacy and safety for a variety of patients. What does it all mean to practitioners in the clinic?Post test for CME/CE credit: https://elit.dkbmed.com/issues/195/test Hosted on Acast. See acast.com/privacy for more information.
--------
25:30
COVID-19: Then and Now
Hosted on Acast. See acast.com/privacy for more information.
--------
25:36
Steroids, Dyspnea, and COVID: Clinical Challenges in COPD Management
In early 2022, the state of the art for managing patients with COPD continues to present challenges. When, how, and in whom are inhaled steroids the most effective way to reduce exacerbations? Are the GOLD guidelines still relevant? What do patients with COPD need to know about the dangers and long-term effects of COVID-19 infection? These are some of the questions we discuss with our guest, Dr. Nirupama Putcha from the Division of Pulmonology and Critical Care at the Johns Hopkins University School of Medicine, in this issue of ePulmonology Review. Take our post-test to claim CME credits. Hosted on Acast. See acast.com/privacy for more information.
--------
19:23
Asthma Management: The Current State of the Art in Early 2022
Managing patients with asthma continues to grow more complex. Two key guidelines have recently been updated. Where do their recommendations concur? Where do they differ, and why? Where do the newer biologic agents fit into evolving treatment paradigms? Which patients are likely to benefit, and in which are specific biologics inappropriate? These are some of the questions we discuss with Dr. Ashraf Fawzy, from the Division of Pulmonology and Critical Care at Johns Hopkins University, in this ePulmonology Review podcast. Take our post-test to claim CME credits.To read a companion newsletter click here. Hosted on Acast. See acast.com/privacy for more information.
This new eLiterature Review series provides up-to-date information directly relevant to clinical practice for clinicians interested in pulmonology. Topic-focused newsletters summarize and provide an expert perspective on the most relevant peer-reviewed articles, while keeping readers current on the latest clinical data. Accompanying podcasts take information from the newsletters and apply it to case-based scenarios. Hosted on Acast. See acast.com/privacy for more information.
Polska